Name

TPDC-FUHU

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for TPDC-FUHU

Name

Alternate Names

5-Fluorouracil
5-Fluracil
Adrucil
Efudex
Fluoroplex
Fluracil
Fluril
Oracil
Ro 2-9757
WR-69596

Abbreviations

5-FU
5FU
FU

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

019893
19893

Primary Site

Breast- adjuvant setting and advanced disease
colorectal- adjuvant setting and advanced disease
GI malignancies: anal, esophageal, gastric and pancreatic
Head and Neck cancer
Hepatoma
Ovarian cancer
Skin-Basal cell carcinoma (topical application)

Histology

None

Remarks

Fluorinated pyrimidine; antimetabolite. FDA approved uses on basal cell carcinoma, breast cancer, colorectal cancer, gastric cancer, and pancreatic cancer.

Note: Efudex cream be prescribed to treat AIN III. Code this as chemotherapy.

Coding

This drug should be coded

Name

Alternate Names

6-Mercaptoguanine
6-Thioguanine
Lanvis
Tabloid
Tioguanin
WR-1141

Abbreviations

6-TG
TG
TT-6
TT-G

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

752
000752

Primary Site

None

Histology

None

Remarks

A purine analogue antineoplastic agent; antimetabolite. FDA approved use for acute non-lymphocytic leukemia.

Coding

This drug should be coded

Name

Alternate Names

Belustine (nitrosourea)
CeeNu
Chloroethylcyclohexylnitrosourea
ICIG 1109
RB1509
WR-139017

Abbreviations

CCNU

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

079037
79037

Primary Site

Brain tumors: primary or metastatic
Hodgkin lymphoma
Non-Hodgkin lymphoma

Histology

None

Remarks

Cell-cycle nonspecific antineoplastic agent;alkylating agent. FDA approved uses in brain tumor and Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Alternate Names

Dibromdulcit
Elobromol
Mitolac
Mitolactol

Abbreviations

DBD

Category

Chemotherapy

Subcategory

Miscellaneous agent

NSC Number

104800

Primary Site

None

Histology

None

Remarks

Miscellaneous agent

Coding

This drug should be coded

Name

Alternate Names

Ibenzmethyzin Hydrochloride
Matulane
Methylhydrazine
N-Methylhydrazine
Natulan
Natulane
Procarbazine hydrochloride
Ro-4-6467
Ro4-6467/1

Abbreviations

IBZ
MIH
PCB
PCH
PCI
PCZ

Category

Chemotherapy

Subcategory

Nonclassic alkylating agent

NSC Number

077213
77213

Primary Site

Brain tumors adjuvant and/or advanced disease
Cutaneous T-cell lymphoma
Hodgkin lymphoma
Non-Hodgkin lymphoma

Histology

None

Remarks

An orally administered hydrazine derivative antineoplastic agent. FDA approved in stages III, IV Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Alternate Names

Carbamo-hydroximic acid
Carbamohydroxamic acid
Carbamoyl oxime
Droxia
Hidrix
Hydrea
Hydreia
hydroxy-
Hydroxycarbamide
Hydroxycarbamine
Hydroxyl-urea
Hydura
Litaler
Litalir
Onco-Carbide
Oxyurea
SQ-1089
Urea
WR-83799

Abbreviations

HU
HUR
HYD

Category

Chemotherapy

Subcategory

Miscellaneous agent

NSC Number

032065
32065

Primary Site

Brain cancer
CML
Head and neck cancers
Melanoma
Ovarian cancer
Essential thrombocytosis
Polycythemia Vera

Histology

None

Remarks

FDA approved uses on chronic myelogenous leukemia, head and neck cancers, melanoma, and advanced ovarian cancer.

Coding

This drug should be coded
Glossary